Polycythemia vera had been diagnosed six years earlier based on erythrocytosis (hematocrit ~70%), the presence of the JAK2 V617F mutation, and low serum erythropoietin levels (2.1 mIU/mL; normal range: 4-24 mIU/mL). This evidence concerns the gene JAK2 and acquired polycythemia vera.